0001567619-20-009086.txt : 20200505 0001567619-20-009086.hdr.sgml : 20200505 20200505192215 ACCESSION NUMBER: 0001567619-20-009086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200430 FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 20850651 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2020-04-30 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2020-04-30 5 A 0 339 62.586 A 298552 D Common Stock 2020-05-01 4 M 0 4000 21.51 A 302552 D Common Stock 2020-05-01 4 S 0 4000 89.38 D 298552 D Common Stock 2020-05-04 4 M 0 5000 21.51 A 303552 D Common Stock 2020-05-04 4 S 0 5000 88.00 D 298552 D Common Stock 247958 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (Right to buy Common Stock) 21.51 2020-05-01 4 M 0 4000 0 D 2010-11-12 2020-05-11 Common Stock 4000 25000 D Stock Option (Right to buy Common Stock) 21.51 2020-05-04 4 M 0 5000 0 D 2010-11-12 2020-05-11 Common Stock 5000 20000 D Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan. Trade made pursuant to a 10b5-1 plan executed on March 5, 2020. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2020-05-05